Kindbody Vertical Integration Advantage
Kindbody
This split between benefits platforms and clinic operators determines who captures the economics of fertility care. Progyny and Maven mainly sit in the middle of the transaction, they build employer contracts, steer members into outside clinic networks, and negotiate rates, but the procedures still happen somewhere else. Kindbody collapses those layers into one company, so it can sell the employer benefit and also bill for the ultrasound, lab work, egg retrieval, and IVF cycle inside its own clinics.
-
An aggregator model is asset light. Maven serves employers through 1,000 plus contracted providers across 30 plus specialties, operates in 175 countries, and partners with 475 plus fertility clinics, which lets it expand without building clinics city by city.
-
The tradeoff is margin structure. Progyny-like benefits administrators carry heavy pass through treatment costs, and Maven is benchmarked against Progyny at much lower gross margins than Kindbody. Kindbody’s owned clinics and related services are tied to roughly 60% gross margin, because more of each patient dollar stays in house.
-
The employer buyer sees different products. With Maven or Progyny, the employer is buying network access, care navigation, reimbursement administration, and negotiated pricing. With Kindbody, the employer can also direct volume into a branded clinical footprint, which turns the benefits contract into patient acquisition for owned care delivery.
The market is moving toward more vertical integration. As fertility benefits become a standard HR offering, the biggest winners are likely to be companies that control both member acquisition and care delivery, because they can price the benefit, manage utilization, and keep the clinical revenue instead of passing it through to outside providers.